microRNA Expression in Renal Cell Carcinoma
NCT00743054 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2015-05-21
Summary
In this study, renal cell carcinoma (RCC) related miRNA and the target genes of related miRNA will be examined in order to investigate the role of miRNA in the formation of RCC and look for the biomarker of RCC.
Conditions
- Carcinoma, Renal Cell
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Principal Investigators
-
Xueqing Yu, M.D. & Ph.D. · 1st Affiliated Hospital, Sun Yat-Sen University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2009-08-31
- Completion
- 2011-08-31
Countries
- China
Study Locations
More Related Trials
-
Different Genetic Features Associated With Hepatic Carcinogenesis
NCT01247506 ·Status: UNKNOWN
-
The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02450448 ·Status: COMPLETED
-
Role of Geminin and Mcm-2 in Prognosis of Renal Cell Carcinoma
NCT03692533 ·Status: UNKNOWN ·Phase: NA
-
Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes
NCT05534854 ·Status: UNKNOWN
-
Urine Omics Predicting IO Therapy Responses in mRCC Patients
NCT04712305 ·Status: RECRUITING
-
Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
NCT07243067 ·Status: NOT_YET_RECRUITING
-
Molecular Profiling and Molecular Labeling of Inflammatory Myofibroblastic Tumor
NCT04572594 ·Status: UNKNOWN
-
Role of microRNA in the Development of Cutaneous Squamous Cell Carcinoma
NCT01143311 ·Status: TERMINATED ·Phase: NA
-
TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative
NCT03630536 ·Status: ACTIVE_NOT_RECRUITING
-
Moesin Expression in Clear Cell Renal Cell Carcinoma
NCT06055660 ·Status: COMPLETED
-
The Expression and Effect of Cyr61 in Urinary Tract Transitional Cell Carcinoma
NCT01189838 ·Status: UNKNOWN
-
Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor
NCT01453465 ·Status: WITHDRAWN
-
The Difference of microRNA and Circulating Tumor Cells in Blood Among Cancer Patients With Immunotherapy
NCT07260370 ·Status: RECRUITING
-
Molecular Markers in Predicting Response to Treatment in FH-deficient RCC Patients
NCT05535829 ·Status: UNKNOWN
-
Studying Biomarkers in Samples From Younger Patients With Kidney Cancer
NCT01642095 ·Status: WITHDRAWN
-
Expression Levels of RISC and Microprocessor Complex Components in Epithelial Skin Cancer
NCT01345760 ·Status: COMPLETED
-
NANOTECH RCC Biomarkers
NCT02923284 ·Status: COMPLETED
-
Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA
NCT04197414 ·Status: RECRUITING
-
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
NCT05917106 ·Status: RECRUITING
-
Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia
NCT05217407 ·Status: RECRUITING
-
Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.
NCT04213664 ·Status: UNKNOWN
-
The Role of Genetic Mutations and of Circulating mRNAs in Uveal Melanoma
NCT05179174 ·Status: UNKNOWN
-
Biomarkers of Renal Dysfunction in Neuroblastoma Survivors
NCT03947346 ·Status: COMPLETED
-
Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors
NCT01004783 ·Status: COMPLETED
-
Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer
NCT00364715 ·Status: COMPLETED